
Neonatologist, Gooner, father of 3. Co-PI @PLUSSTrial
Melbourne, Victoria
Joined August 2009
- Tweets91
- Following359
- Followers215
- Likes241
Largest trial to date. Outcomes not expected and non-congruent to previously published studies…why? Lots to discuss!! Thanks for leading the study and the debate on this platform @drbretty ! 🧐
8
595
omar kamlin retweeted
Really appreciated this opportunity from @abcnewsradio to talk about our work exploring the first days of preterm life and early diagnosis tools. @DavidTingay @drbretty @3HKam
"We can specifically target those processes...before it really develops into...chronic lung disease." #MCRI's Dr Prue Pereira-Fantini has spoken to ABC News Radio, about how preterm baby's blood can show early signs of lung damage | #MedicalResearch @dr_prue @abcnews
Listen 👇
omar kamlin retweeted
Almost time for the @PlussTrial talk at #PAS2024 😊
Great to see these centiles in print . Time well spent on the labour wards😀. Congrats!
Our new NIRS percentiles are out #openaccess. Along with recent HR & SpO2 perc's (link in thread), these provide reference standards for physiological parameters in transitioning (mostly) term newborns, born by CS and VB, who had deferred cord clamping.
rdcu.be/dFS7h
4
139
omar kamlin retweeted
This is an urgent video, please listen to all of it. 🙏🏾❤️🕊️
#useyourvoice
#midwifery #midwife #miscarriageawareness #waronchildren #waronmothers
@UNFPA @savechildrenuk @chooselove
omar kamlin retweeted
Over 80 perinatal clinicians and researchers from around ANZ 🇦🇺🇳🇿 joined our first PLATIPUS investigators meeting!
Wonderful to see so much support for the concept; and for the first 2 planned domains:🫄🦠 & 👶☕️
#PLATIPUStrial #neoEBM
omar kamlin retweeted
Look forward to seeing many ANZ perinatal researchers and clinicians at the first PLATIPUS Investigators Meeting at 3pm AEST today on Zoom!
Hopefully you’ve all received the link by email but let us know if you haven’t!
The 9️⃣0️⃣0️⃣th extremely preterm infant was enrolled in the @PlussTrial today. Amazing!! 🤩
We are 85% of the way to the target sample size of 1060! 📈
Incredible work from all our centres in 4 countries 🇦🇺🇳🇿🇨🇦🇸🇬
#neoEBM #neoTwitter @MCRI_for_kids
1
Fantastic news and what a great start! Many congratulations to all involved from regulatory efforts, Karen as PI, clinical teams and of course the families
Very excited to have recruited the first 2 babies in @PolarTrial this evening!
Fantastic team work from neonatal team @wishawneonatal and special thanks to Dr Karen McCall our trial PI for her great support. @WishawGen @kate84boyle
1
5
An Amazing Effort to match an equally Spectacular Milestone! Big shout out to the dedicated and committed teams involved and to trust of the families at at time of extreme stress for them to tackle gaps in our knowledge
The 8️⃣5️⃣0️⃣th extremely preterm infant was enrolled in the @PlussTrial today.
That means we are more than 8️⃣0️⃣% of the way to our target sample size of 1060!! 📈
Incredible work from our 18 centres in 4 countries 🇦🇺🇳🇿🇨🇦🇸🇬
#neoEBM #neoTwitter
omar kamlin retweeted
💥 The @PlussTrial has enrolled its 8️⃣0️⃣0️⃣th baby!🇦🇺🇳🇿🇨🇦🇸🇬
@MercyHealthAus @Akld_DHB @CCDHB @cmdhb @HNEHealth @ACT_CHS @SEastSydHealth @NthSydHealth @MaterNews @Research4Babies @thewomens @MonashChildrens @Flinders @CanterburyDHB #RBWH #KKWCH #KEMH
omar kamlin retweeted
SHINE trial published yesterday in @NEJM
RCT of nasal high flow to improve success of first intubation
NNT of 6!
Summarised beautifully by lead author @katehodg18 in the thread below 👇🏻👇🏻👇🏻👇🏻👇🏻
This Post is from an account that no longer exists. Learn more
omar kamlin retweeted
Nasal high-flow therapy during neonatal endotracheal intubation increased the likelihood of successful intubation on the first attempt without physiological instability. nej.md/3EICGja
For a friend.... Join me and @BreastCancerNow to call on @NICEComms and @NHSEngland to find a solution to ensure triple negative secondary breast cancer drug, Trodelvy, is accessible on the NHS. Sign the open letter! #TimeForTrodelvy action.breastcancernow.org/t…
1
omar kamlin retweeted
For preterm infants with RDS supported w/ CPAP, does selective surfactant administration via thin catheter at a low oxygenation threshold improve survival without BPD compared w/ continuation of CPAP?
A new RCT published @JAMA_current
#neoEBM #EBNEOAlerts
ow.ly/Xbq050Hf3k6




















